COSCIENS Biopharma Intangible Assets

COSCIENS Biopharma (AEZS) currently reports a intangible assets of $3.3M as of June 2024. That compares with $11K in the prior-year period — up 29928.8% year over year. Use the charts on this page to explore COSCIENS Biopharma's intangible assets history and peer comparisons.

COSCIENS Biopharma's intangible assets increased from $11K to $3.3M — a 29928.8% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSCIENS Biopharma reported $3.3M in intangible assets as of June 2024. That compares with $11K in the prior-year period — up 29928.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $3.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSCIENS Biopharma, and consider following AEZS for alerts when major investors trade the stock.

COSCIENS Biopharma is classified in the Healthcare sector. On intangible assets, it currently shows $3.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AEZS with unrelated industries.